Seven Cash-Backed Software Names After the Selloff

Neocloud names cracked first when October 2026 turned cold on AI credit. Nebius slid 15.1% in a single session while CoreWeave gave up 9.5%, leaving CoreWeave down roughly 25% across the month and Nebius about 20% lower. CNBC traced the rupture in an October 15 explainer, Yahoo linked the slide to widening debt fear, and Investing logged the session damage across Applied Digital at minus 8.8%, IREN at minus 9.9%, Oracle at minus 7.2%, Dell at minus 10.3% and HPE at minus 6.4% after a Barclays downgrade.

The setup echoes the late-1990s boom and bust the creator uses as a frame. Nasdaq surged 555% between 1994 and 2000 before rising rates drained funding; Lucent fell 99% and ended in an Alcatel fire sale, Oracle needed 15 years to retake its 2000 peak, and Amazon cratered 94% into 2001 before compounding 869% over the next 15 years and 7,700% across 25. Builders of raw capacity suffered most, while appliers of the technology recovered and then dominated.

Why 2000 still rhymes

Today rhymes through rates and opaque revenue. CoreWeave's 2032 bonds yield near 15%, a distressed level, against debt plus lease obligations near $52B at the end of June; Q2 interest reached $640M, more than double the prior year, leverage sat at 5.8 times annualized Q2 EBITDA, and Visible Alpha expects roughly $25B in negative free cash flow this year ahead of Q3 results on November 11. Yahoo detailed that leverage load, Investing covered the rate-driven session, and Goldman Sachs data showed US high-yield AI debt spreads widening 25 basis points across October 13-14 to 360 over Treasurys, centered on neocloud corporate bonds, even as chief executive Intrator called the trading irrational.

Listing that could force honesty

A listing could supply the honesty moment. CNBC reported on October 19 that Anthropic stands as the only major 2026 IPO hope with Kalshi odds at 75%, following a confidential S-1 in June, while OpenAI ruled out 2026 after Altman called such timing ill-advised and pointed to 2027 at the earliest. Anthropic posted Q3 revenue of $16.8B on weaker sequential growth, its valuation range was cut to start at $1.5T from $2T, and Renaissance counts US IPOs down 33% against 2025. The thesis cited in the video holds that a crash accelerates three to six months after an Anthropic debut, once quarterly reports expose the trend.

Survival comes before selection in this playbook. Positions grow slowly with monthly adds, and a cash reserve stays parked for the crash itself, because only balance sheets with real cash generation live through a funding drought. That filter, steady revenue plus staying power, decides every name below.

Seven appliers worth studying

UiPath brings autonomous automation with orchestration plus developer-tool integration, and Forrester ranks it a leader. Its investor-relations filing shows fiscal 2026 revenue of $1.611B, up 13%, with Q4 revenue of $481M, up 14%, ARR of $1.853B, up 11%, full-year operating cash flow of $371M and cash plus securities of $1.69B at January 31, 2026; Q1 fiscal 2027 ARR reached $1.901B, up 12%, against cash of $1.42B. UiPath strength sits in that cash pile, while competition with Microsoft and OpenAI forms the key risk, and the video cites a $15.57 average target implying near 20% upside across 17 analysts.

ServiceNow sells control for autonomous rollouts through its AI Control Tower and the Otto unified experience, with deployments up ninefold in nine months plus a Microsoft 365 workflow extension. Its investor-relations release shows Q2 subscription revenue of $3.877B, up 24.5%, total revenue of $3.987B, up 24%, current remaining performance obligations of $13.2B, up 21%, total remaining obligations of $29B, up 21%, AI products above $1B in annual contract value, operating cash flow of $587M and free cash flow of $634M. Microsoft and Salesforce competition is the cited risk, and the video cites a $155 average target implying near 10% upside across 32 analysts.

Palantir links company data with operations across manufacturing, hospitals and defense through its AIP setup. Its investor-relations release shows Q2 revenue of $1.935B, up 93% against a $1.80B consensus, US commercial revenue up 149%, US government revenue up 90% to $809M, and raised full-year guidance toward 82% growth. Valuation is the risk, at 163 times earnings and 80 times sales, with a patient entry near $150 to $160 floated; the video cites a $212 average target for 13% upside beside an $80 bear case implying a 57% drop.

Cloudflare runs a connectivity cloud with a developer platform built for autonomous workloads. Its Q2 release shows revenue of $696.1M, up 36%, non-GAAP operating income of $96.1M, free cash flow of $56.4M, cash of $4.16B and 4,698 large customers, up 27% on record additions, with Q3 guidance of $736M to $737M. The video cites a $358 average target implying 21% upside across 27 analysts, beside a $160 bear case.

SoundHound pairs voice interfaces with autonomous enterprise software through its OASYS platform. Its investor-relations release shows record Q2 revenue of $61.9M, up 45%, alongside a raised full-year outlook, GAAP gross margin of 45.1%, non-GAAP margin of 58.4%, adjusted EBITDA of minus $9.6M and a GAAP net loss of $42.8M. It never produced positive cash flow and still needs outside financing, which is the core risk; the video cites an $11 average target across five analysts with a $6 low.

Tempus blends precision medicine with data licensing. Its investor-relations release shows Q2 revenue of $382.5M, up 22%, diagnostics revenue of $289.3M, up 20%, oncology volume up 31%, data and applications revenue of $93.2M, up 28%, insights revenue up 36%, fresh bookings near $200M, raised full-year guidance of $1.595B to $1.605B for about 25% growth, adjusted EBITDA near $65M, cash of $820.7M and net income of $5.6M, plus a Personalis purchase near $1.5B in enterprise value, a joint research setup with AstraZeneca and an FDA approval for a tumor-only xT test. Cash burn and healthcare regulation are the risks, and the video cites a $73 average target across 15 analysts.

Snowflake offers its AI Data Cloud with Cortex AI and Snowflake Intelligence, and the SEC record, drawn from its EDGAR filing, carries the hard figures. Product revenue reached $1.334B in fiscal Q1 2027, up 34%, total revenue hit $1.39B, up 33%, net revenue retention printed 126%, the customer count rose by 616, and the raised full-year guide sees product revenue of $5.84B, up 31%, with a 13.5% operating margin and a 23% free-cash-flow margin; its Cortex developer offering sits inside 7,100-plus accounts, and the Natoma purchase adds context-protocol technology. The video cites a $438 average target implying 41% upside across 35 analysts, beside a $360 low.

Positioning through a crash

A genuine crash would drag even these names down first, then let the appliers rebound while debt-heavy builders restructure. Gradual buying with reserves held back matches that sequence, and position sizes should fit a household plan built with a licensed professional rather than a video thesis.